CLINICAL_TRIALS
trial_result
· 2025-06-03
Clinical Trial Update: Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab [Phase 1]
Summary
Phase 1 clinical trial evaluating glucagon rescue of insulin-induced hypoglycemia in adults with Type 1 diabetes treated with volagidemab has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: REMD Biotherapeutics, Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED